Press Releases | ARUP Laboratories

Press Releases

Magnify Magazine

Media Resources

Press Releases

microscope

Magnify Magazine

microscope

Media Resources

microscope

Medical laboratory professionals such as this pair at work at ARUP are in high demand. The U.S. Bureau of Labor Statistics estimated that nearly 26,000 more of these highly trained specialists will be needed each year through 2030.	January 10, 2023	Advanced Practice Clinical Laboratory Training Center at ARUP Secures $3 Million in Federal Efforts to train more medical laboratory scientists have been greatly boosted by $3 million in federal funds for a clinical lab training center that ARUP will build with the University of Utah.
The U.S. Food and Drug Administration (FDA) has updated its blood donation guidelines to remove a former ban related to concern about variant Creutzfeldt-Jakob disease (vCJD) transmission.	January 9, 2023	Individuals Who Lived and Worked in Parts of Europe Now Eligible to Donate Blood The U.S. Food and Drug Administration (FDA) has updated its guidelines to allow individuals who lived or worked in the United Kingdom, France, or Ireland to donate blood and platelets.
	December 1, 2022	ARUP Honored With Utah Business Magazine’s Best Companies To Work For Award ARUP’s culture of caring has earned it Utah Business magazine’s Best Companies To Work For Award for a fifth consecutive year.
	November 9, 2022	ARUP Announces Successful Completion of CAP ISO 15189 Assessment ARUP’s International Organization for Standardization (ISO) 15189 accreditation assessment has successfully concluded, and results confirm the consistently high quality of ARUP’s operations.
	September 26, 2022	AAV5 DetectCDx™ Kit Is First ARUP Test Developed to Support a New Therapy The European Commission’s approval of BioMarin’s novel gene therapy for severe hemophilia A has paved the way for ARUP’s AAV5 DetectCDx™ Kit to become the first ARUP-developed test used in Europe.
NanoSpot.ai’s agreement with the Greek company Opto enables the commercialization and distribution in Europe of NanoSpot.ai’s line of antibody tests, including the SARS-CoV-2 test pictured here.	September 14, 2022	NanoSpot.ai Announces Partnership With Opto to Commercialize SARS-CoV-2 Antibody Test in NanoSpot.ai’s European commercialization agreement is the first for an antibody test originally developed through an ARUP/University of Utah/Techcyte partnership.